ID   UBP30_HUMAN             Reviewed;         517 AA.
AC   Q70CQ3; Q8WTU7; Q96JX4; Q9BSS3;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   10-MAY-2017, entry version 124.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 30;
DE            EC=3.4.19.12 {ECO:0000269|PubMed:14715245};
DE   AltName: Full=Deubiquitinating enzyme 30;
DE   AltName: Full=Ubiquitin thioesterase 30;
DE   AltName: Full=Ubiquitin-specific-processing protease 30;
DE            Short=Ub-specific protease 30;
GN   Name=USP30 {ECO:0000312|HGNC:HGNC:20065};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=14715245; DOI=10.1016/j.bbrc.2003.12.050;
RA   Quesada V., Diaz-Perales A., Gutierrez-Fernandez A., Garabaya C.,
RA   Cal S., Lopez-Otin C.;
RT   "Cloning and enzymatic analysis of 22 novel human ubiquitin-specific
RT   proteases.";
RL   Biochem. Biophys. Res. Commun. 314:54-62(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 24-517.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF ARG-28; LYS-30; LYS-33;
RP   59-ARG--LYS-64 AND CYS-77, AND ACTIVE SITE.
RX   PubMed=18287522; DOI=10.1091/mbc.E07-11-1103;
RA   Nakamura N., Hirose S.;
RT   "Regulation of mitochondrial morphology by USP30, a deubiquitinating
RT   enzyme present in the mitochondrial outer membrane.";
RL   Mol. Biol. Cell 19:1903-1911(2008).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, ACTIVE SITE, MUTAGENESIS OF CYS-77,
RP   AND UBIQUITINATION AT LYS-235 AND LYS-289.
RX   PubMed=24896179; DOI=10.1038/nature13418;
RA   Bingol B., Tea J.S., Phu L., Reichelt M., Bakalarski C.E., Song Q.,
RA   Foreman O., Kirkpatrick D.S., Sheng M.;
RT   "The mitochondrial deubiquitinase USP30 opposes parkin-mediated
RT   mitophagy.";
RL   Nature 510:370-375(2014).
RN   [6]
RP   FUNCTION.
RX   PubMed=25527291; DOI=10.15252/embj.201489847;
RA   Wauer T., Swatek K.N., Wagstaff J.L., Gladkova C., Pruneda J.N.,
RA   Michel M.A., Gersch M., Johnson C.M., Freund S.M., Komander D.;
RT   "Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain
RT   assembly and hydrolysis.";
RL   EMBO J. 34:307-325(2015).
RN   [7]
RP   FUNCTION, MUTAGENESIS OF CYS-77, AND ACTIVE SITE.
RX   PubMed=25621951; DOI=10.1038/ncb3097;
RA   Cunningham C.N., Baughman J.M., Phu L., Tea J.S., Yu C., Coons M.,
RA   Kirkpatrick D.S., Bingol B., Corn J.E.;
RT   "USP30 and parkin homeostatically regulate atypical ubiquitin chains
RT   on mitochondria.";
RL   Nat. Cell Biol. 17:160-169(2015).
CC   -!- FUNCTION: Deubiquitinating enzyme tethered to the mitochondrial
CC       outer membrane that acts as a key inhibitor of mitophagy by
CC       counteracting the action of parkin (PRKN): hydrolyzes ubiquitin
CC       attached by parkin on target proteins, such as RHOT1/MIRO1 and
CC       TOMM20, thereby blocking parkin's ability to drive mitophagy
CC       (PubMed:18287522, PubMed:24896179, PubMed:25527291,
CC       PubMed:25621951). Preferentially cleaves 'Lys-6'- and 'Lys-11'-
CC       linked polyubiquitin chains, 2 types of linkage that participate
CC       to mitophagic signaling (PubMed:25621951). Does not cleave
CC       efficiently polyubiquitin phosphorylated at 'Ser-65'
CC       (PubMed:25527291). Acts as negative regulator of mitochondrial
CC       fusion by mediating deubiquitination of MFN1 and MFN2 (By
CC       similarity). {ECO:0000250|UniProtKB:Q3UN04,
CC       ECO:0000269|PubMed:18287522, ECO:0000269|PubMed:24896179,
CC       ECO:0000269|PubMed:25527291, ECO:0000269|PubMed:25621951}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:14715245}.
CC   -!- ENZYME REGULATION: Inhibited by the diterpenoid derivative 15-
CC       oxospiramilactone (S3). {ECO:0000250|UniProtKB:Q3UN04}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:18287522, ECO:0000269|PubMed:24896179}.
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle, pancreas, liver
CC       and kidney. {ECO:0000269|PubMed:14715245}.
CC   -!- PTM: Ubiquitinated by parkin (PRKN) at Lys-235 and Lys-289,
CC       leading to its degradation. {ECO:0000269|PubMed:24896179}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH04868.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB55392.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ586136; CAE51936.1; -; mRNA.
DR   EMBL; BC004868; AAH04868.1; ALT_INIT; mRNA.
DR   EMBL; BC022094; AAH22094.2; -; mRNA.
DR   EMBL; AK027820; BAB55392.1; ALT_INIT; mRNA.
DR   CCDS; CCDS9123.2; -.
DR   RefSeq; NP_001288104.1; NM_001301175.1.
DR   RefSeq; NP_116052.2; NM_032663.4.
DR   RefSeq; XP_006719716.1; XM_006719653.3.
DR   UniGene; Hs.486434; -.
DR   UniGene; Hs.660996; -.
DR   ProteinModelPortal; Q70CQ3; -.
DR   BioGrid; 124238; 26.
DR   DIP; DIP-53578N; -.
DR   IntAct; Q70CQ3; 6.
DR   STRING; 9606.ENSP00000257548; -.
DR   MEROPS; C19.060; -.
DR   iPTMnet; Q70CQ3; -.
DR   PhosphoSitePlus; Q70CQ3; -.
DR   BioMuta; USP30; -.
DR   DMDM; 52000872; -.
DR   EPD; Q70CQ3; -.
DR   MaxQB; Q70CQ3; -.
DR   PaxDb; Q70CQ3; -.
DR   PeptideAtlas; Q70CQ3; -.
DR   PRIDE; Q70CQ3; -.
DR   DNASU; 84749; -.
DR   Ensembl; ENST00000257548; ENSP00000257548; ENSG00000135093.
DR   GeneID; 84749; -.
DR   KEGG; hsa:84749; -.
DR   UCSC; uc010sxi.3; human.
DR   CTD; 84749; -.
DR   GeneCards; USP30; -.
DR   HGNC; HGNC:20065; USP30.
DR   HPA; HPA016952; -.
DR   MIM; 612492; gene.
DR   neXtProt; NX_Q70CQ3; -.
DR   OpenTargets; ENSG00000135093; -.
DR   PharmGKB; PA134971149; -.
DR   eggNOG; KOG1867; Eukaryota.
DR   eggNOG; ENOG410XQQ0; LUCA.
DR   GeneTree; ENSGT00550000075075; -.
DR   HOGENOM; HOG000065744; -.
DR   HOVERGEN; HBG079301; -.
DR   InParanoid; Q70CQ3; -.
DR   KO; K11851; -.
DR   OMA; CENCTKL; -.
DR   OrthoDB; EOG091G0D1P; -.
DR   PhylomeDB; Q70CQ3; -.
DR   TreeFam; TF105781; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP30; human.
DR   GenomeRNAi; 84749; -.
DR   PRO; PR:Q70CQ3; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135093; -.
DR   CleanEx; HS_USP30; -.
DR   ExpressionAtlas; Q70CQ3; baseline and differential.
DR   Genevisible; Q70CQ3; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0008053; P:mitochondrial fusion; ISS:UniProtKB.
DR   GO; GO:0000422; P:mitophagy; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB.
DR   GO; GO:0044313; P:protein K6-linked deubiquitination; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00443; UCH; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Hydrolase; Isopeptide bond; Membrane;
KW   Mitochondrion; Mitochondrion outer membrane; Polymorphism; Protease;
KW   Reference proteome; Thiol protease; Transmembrane;
KW   Transmembrane helix; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN         1    517       Ubiquitin carboxyl-terminal hydrolase 30.
FT                                /FTId=PRO_0000080662.
FT   TOPO_DOM      1     35       Mitochondrial intermembrane.
FT                                {ECO:0000255}.
FT   TRANSMEM     36     56       Helical. {ECO:0000255}.
FT   TOPO_DOM     57    517       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       68    502       USP.
FT   ACT_SITE     77     77       Nucleophile.
FT                                {ECO:0000269|PubMed:18287522,
FT                                ECO:0000269|PubMed:24896179,
FT                                ECO:0000269|PubMed:25621951}.
FT   ACT_SITE    452    452       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   CROSSLNK    235    235       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:24896179}.
FT   CROSSLNK    289    289       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:24896179}.
FT   VARIANT     357    357       H -> R (in dbSNP:rs16939904).
FT                                /FTId=VAR_059751.
FT   MUTAGEN      28     28       R->T: No change in mitochondrial
FT                                subcellular location; when associated
FT                                with N-30 and N-33.
FT                                {ECO:0000269|PubMed:18287522}.
FT   MUTAGEN      30     30       K->N: No effect on subcellular location;
FT                                when associated with N-28 and N-33.
FT                                {ECO:0000269|PubMed:18287522}.
FT   MUTAGEN      33     33       K->N: No effect on subcellular location;
FT                                when associated with N-28 and N-30.
FT                                {ECO:0000269|PubMed:18287522}.
FT   MUTAGEN      59     64       RKKRRK->NNASNN: Loss of mitochondrial
FT                                subcellular location. Located in the
FT                                endoplasmic reticulum.
FT                                {ECO:0000269|PubMed:18287522}.
FT   MUTAGEN      77     77       C->S: Loss of deubiquitinase activity and
FT                                impaired ability to inhibit mitophagy.
FT                                Increased TOMM20 ubiquitination.
FT                                {ECO:0000269|PubMed:18287522,
FT                                ECO:0000269|PubMed:24896179,
FT                                ECO:0000269|PubMed:25621951}.
SQ   SEQUENCE   517 AA;  58503 MW;  68FA9B9BEBCFF8DF CRC64;
     MLSSRAEAAM TAADRAIQRF LRTGAAVRYK VMKNWGVIGG IAAALAAGIY VIWGPITERK
     KRRKGLVPGL VNLGNTCFMN SLLQGLSACP AFIRWLEEFT SQYSRDQKEP PSHQYLSLTL
     LHLLKALSCQ EVTDDEVLDA SCLLDVLRMY RWQISSFEEQ DAHELFHVIT SSLEDERDRQ
     PRVTHLFDVH SLEQQSEITP KQITCRTRGS PHPTSNHWKS QHPFHGRLTS NMVCKHCEHQ
     SPVRFDTFDS LSLSIPAATW GHPLTLDHCL HHFISSESVR DVVCDNCTKI EAKGTLNGEK
     VEHQRTTFVK QLKLGKLPQC LCIHLQRLSW SSHGTPLKRH EHVQFNEFLM MDIYKYHLLG
     HKPSQHNPKL NKNPGPTLEL QDGPGAPTPV LNQPGAPKTQ IFMNGACSPS LLPTLSAPMP
     FPLPVVPDYS SSTYLFRLMA VVVHHGDMHS GHFVTYRRSP PSARNPLSTS NQWLWVSDDT
     VRKASLQEVL SSSAYLLFYE RVLSRMQHQS QECKSEE
//
